crc press - E-Lib FK UWKS

344 Cell-Penetrating Peptides: Processes and Applications
REFERENCES
1. Dubowchik, G.M. and Walker, M.A., Receptor-mediated and enzyme-dependent targeting
of cytotoxic anticancer drugs, Pharmacol. Ther., 83, 67, 1999.
2. Reddy, J.A. and Low, P.S., Folate-mediated targeting of therapeutic and imaging
agents to cancers, Crit. Rev. Ther. Drug Carrier Syst., 15, 587, 1998.
3. Marecos, E. et al., Antibody-mediated vs. nontargeted delivery in a human small cell
lung carcinoma model, Bioconjug. Chem., 9, 184, 1998.
4. Rojas, M. et al., Genetic engineering of proteins with cell membrane permeability,
Nat. Biotechnol., 16, 370, 1998.
5. Prochiantz, A., Messenger proteins: homeoproteins, Tat and others, Curr. Opin. Cell
Biol., 12, 400, 2000.
6. Lindgren, M. et al., Cell-penetrating peptides, Trends Pharmacol. Sci., 21, 99, 2000.
7. Fawell, S. et al., Tat-mediated delivery of heterologous proteins into cells, Proc. Natl.
Acad. Sci. U.S.A., 91, 664, 1994.
8. Vivés, E. et al., A truncated HIV-1 Tat protein basic domain rapidly translocates
through the plasma membrane and accumulates in the cell nucleus, J. Biol. Chem.,
272, 16010, 1997.
9. Derossi, D. et al., Cell internalization of the third helix of the Antennapedia homeodomain
is receptor-independent, J. Biol. Chem., 271, 18188, 1996.
10. Pooga, M. et al., Cell penetration by transportan, FASEB. J., 12, 67, 1998.
11. Soomets, U. et al., Deletion analogues of transportan, Biochim. Biophys. Acta, 1467,
165, 2000.
12. Avrameas, A. et al., Polyreactive anti-DNA monoclonal antibodies and a derived
peptide as vectors for the intracytoplasmic and intranuclear translocation of macromolecules,
Proc. Natl. Acad. Sci. U.S.A., 95, 5601, 1998.
13. Phelan, A. et al., Intercellular delivery of functional p53 by the herpesvirus protein
VP22, Nat. Biotechnol., 16, 440, 1998.
14. Elliott, G. and O’Hare, P., Intercellular trafficking and protein delivery by a herpesvirus
structural protein, Cell, 88, 223, 1997.
15. Sheldon, K. et al., Loligomers: design of de novo peptide-based intracellular vehicles,
Proc. Natl. Acad. Sci. U.S.A., 92, 2056, 1995.
16. Zhang, L. et al., Preparation of functionally active cell-permeable peptides by singlestep
ligation of two peptide modules, Proc. Natl. Acad. Sci. U.S.A., 95, 9184, 1998.
17. Efthymiadis, A. et al., The HIV-1 Tat nuclear localization sequence confers novel
nuclear import properties, J. Biol. Chem., 273, 1623, 1998.
18. Pepinsky, R.B. et al., Specific inhibition of a human papillomavirus E2 trans-activator
by intracellular delivery of its repressor, DNA Cell Biol., 13, 1011, 1994.
19. Anderson, D.C. et al., Tumor cell retention of antibody Fab fragments is enhanced
by an attached HIV TAT protein-derived peptide, Biochem. Biophys. Res. Commun.,
194, 876, 1993.
20. Bayley, H., Protein therapy-delivery guaranteed, Nat. Biotechnol., 17, 1066, 1999.
21. Nagahara, H. et al., Transduction of full-length TAT fusion proteins into mammalian
cells: TAT-p27Kip1 induces cell migration, Nat. Med., 4, 1449, 1998.
22. Vocero–Akbani, A.M. et al., Killing HIV-infected cells by transduction with an HIV
protease- activated caspase-3 protein, Nat. Med., 5, 29, 1999.
23. Pooga, M. et al., Cellular translocation of proteins by transportan, FASEB. J., 15,
1451, 2001.
24. Lin, Y.Z. et al., Inhibition of nuclear translocation of transcription factor NF-kappa
B by a synthetic peptide containing a cell membrane-permeable motif and nuclear
localization sequence, J. Biol. Chem., 270, 14255, 1995.